-1.png?width=90&height=90&name=HBI%20SPOT%20white%20transparent%202026%20(2)-1.png)
.png?width=90&height=90&name=HBI%20SPOT%20white%20transparent%202026%20(2).png)
The HBI Session Video Library
On-demand access to some of HBI’s most impactful sessions. From strategy and investment to AI, operations and clinical innovation.
.png?width=2000&height=1544&name=Video%20Library%20TN%20(2000%20x%201544%20px).png)
%20(2).png?width=2000&height=1544&name=Video%20Library%20TN%20(2000%20x%201544%20px)%20(2).png)
%20(3).png?width=2000&height=1544&name=Video%20Library%20TN%20(2000%20x%201544%20px)%20(3).png)
%20(4).png?width=2000&height=1544&name=Video%20Library%20TN%20(2000%20x%201544%20px)%20(4).png)
%20(5).png?width=2000&height=1544&name=Video%20Library%20TN%20(2000%20x%201544%20px)%20(5).png)
%20(6).png?width=2000&height=1544&name=Video%20Library%20TN%20(2000%20x%201544%20px)%20(6).png)
Session Video
Can you balance commercial and clinical excellence?
Case studies in process, investment, culture and governance
Offering the highest quality service and outcomes to a patient often means using the latest technology or drugs, which doesn’t always tally up with a business looking to contain costs and deliver within budget. In a system limited by resource balancing the delivery of quality and efficiency is where a lot of time is spent which can create friction between clinical and operational staff. But does that have to be the case? This case study-based session outlines multiple models where efficient process design, strong culture focus and new governance models leads to a balance of both clinical and commercial excellence. It explores how to achieve this balance, the investment and structural changes needed and how to deploy such models across different sectors and geographies.
Speakers:
- Sofia Palmquist, Group CEO, Aleris
- Emmanuel De Geuser, Chief Executive Officer, Vivalto Santé
- Ivo Piest, Chief Development Officer, Bergman Clinics
Moderated by :
-Thomas Hagemeijer, Founder, HGM
.jpg)
Session Video
The 2025 Healthcare M&A Landscape?
What does the rest of 2025 have in store for the deal environment across EMEA? What are the options for exits? Who will budge first when it comes to valuation expectations and what is the impact of a changing interest rates and inflation on the back of multiple elections and geopolitical risks in key global markets.
Speakers:
- Hedley Goldberg, Partner & Global Head of Healthcare, Rothschild & Co.
Session Video
Disruptive Innovation: How Investment is transforming healthcare
Healthcare is in the midst of fundamental change where the perfect blend of rising demand and rapid advances in technology has created an environment perfect for disruptive innovation. The real challenge is picking the right investments to leverage this wave of innovation and that will perform in the long term, whilst balancing performance in the short and medium term. Success relies on agility, strong leadership and bold partnerships, where health services, industry, investors, governments, payors and regulators work together towards a common goal; lasting transformation. This opening session features a series of keynote presentations from across the healthcare ecosystem and sets the scene for the case studies and ideas shared during the rest of HBI 2025.
Speakers:
- Johannes Virkkunen, Head of Life Sciences and Transaction Services, EIF
- Bernd Ohnesorge, President, EMEA, Siemens Healthineers
- Florence Dupré, Global Healthcare Officer, La Poste
- Liselot Kilaas, Group CEO, evidia
Moderated by :
- Lee Murray, Event Director, HBI
.jpg?width=2000&name=126-_RVT0739%20(1).jpg)
.jpg?width=2000&name=108-_RVT0635%20(1).jpg)
Session Video
What Lies Ahead? Investor Perspectives On The Next 12 Months
How do major investors in the sector view the opportunities and challenges in the next 12 months? What sectors do they see promise in and where have interests tailed off? Which Megatrends are they pursuing? What innovations and new models do they have their sights set on?
Speakers:
- Angelika Schöchlin, Managing Partner, Antin Infrastructure Partners
- Rainer Lenhard, Partner and Head of DACH Region, Nordic Capital
- Youssef Haidar, Founder and Senior Director, Nexus Gulf
Moderated by :
- Martin Henrichs, Managing Director, Head of Healthcare EMEA, UBS
Session Video
The Disruptive Role Of AI & Real-World Evidence In Delivering 4P Medicine
The concept of 4P Medicine - Prevention, Prediction, Personalized, and Participatory - represents a significant shift towards personalized healthcare delivery, enabled by technological advances. Innovations in clinical trials and drug development have produced vast amounts of real-world evidence (RWE), showing lower costs and better outcomes. By leveraging AI and machine learning (ML), healthcare systems can use RWE to develop algorithms that identify diseases earlier, more accurately, and improve patient access to care. Predictive analytics enhance early disease detection and outcome forecasting, while personalized treatment plans and participatory medicine empower patients and improve engagement. Implementing this model requires collaboration among healthcare stakeholders, ethical data use, regulatory compliance, and strategies for scaling and sustainability. This session will explore practical steps and share insights from various stakeholders to achieve this transformative approach in healthcare.
Speakers:
- Jorg Debatin, Chairman, Honic
- Rainer Lenhard, Partner and Head of DACH Region, Nordic Capital
- Dr Imane Moest, International Business Leader Chronic Remote Care, Roche Information Solutions
- Jorge Fernandez, Chief Innovation Officer, Hospital Clinic de Barcelona
Moderated by :
- Lee Murray, Event Director, HBI
Session Video
From Lifespan To Health Span: Investing Along The Healthcare-Wellness Spectrum
Richer, older, sicker and more demanding populations are creating the need for healthcare products and services to be more specialised, more integrated, more outcome focussed, and more technology driven. These drivers have created an environment where companies pivot to address patients as consumers who are taking charge of their own health, which in turn has thrown up a grey zone for businesses of increased regulatory, payor and scientific risk. In response a new wave of business models and offerings have hit the market that attempt to bridge this healthcare-wellness divide. This data driven presentation takes a global view of the new businesses that are being built across the entire value chain and explains what this means for investment decisions and the future of healthcare delivery.
Speakers:
- Chinta Bhagat, Founder, Aries Holdings
Download the Full
HBI 2025 Conference Report
Access the full write-up of HBI 2025's key sessions including:
- The 2025 Healthcare M&A Landscape
- Disruptive Innovation: How Investment is transforming healthcare
- Can you balance commercial and clinical excellence?
- What lies ahead? Investor perspectives on the next 12 months
- Preparing for growth, acquisitions & exit
...and many more!